Variants at CHR8Q24.21 confer risk of cancer
A cancer, risk technology, applied in the diagnosis of cancer susceptibility in subjects, the field of cancer susceptibility, can solve the problems of unclear molecular and biological mechanisms of melanoma cells
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0209] Example 1 Identification of Regions Associated with Cancer
[0210] Research
[0211] A region on chromosome 8q24.21 has been identified that confers an increased risk for certain cancers, such as prostate cancer. This region was first detected by linkage analysis of prostate cancer (PrCa) families from prostate cancer patients closely related to breast cancer cases.
[0212] Patients Involved in Genetic Studies
[0213] The patient population diagnosed with prostate cancer since 1955 included 3123 patients, about one-third of whom were alive at the time of the study. The patient population diagnosed with breast cancer included 4045 patients. Approximately 950 prostate cancer patients were recruited at the time of the study. We were initially interested in discovering genes that contribute to both prostate and breast cancer. Therefore, we ran the list of our recruited patients against the pedigree database to cover the whole of Iceland. We only included at least t...
Embodiment 2
[0261] Example 2: Prostate cancer association confirmed in several groups (Cohort)
[0262] Additional analyzes further supported the presence of a prostate cancer-associated variant on chromosome 8q24. Allele -8 on microsatellite DG8S737 was associated with prostate cancer in three groups of European pedigrees from Iceland, Sweden and the United States. The estimated relative risk for this allele was 1.62 (P=2.7×10 -11 ). Approximately 19% of patients and 13% of the general population carried at least one copy (PAR=7.4%). This association was also reproduced in the African-American group with similar relative risks. In African-Americans, the frequency of this allele was higher, with 41% of patients and 30% of the population being carriers, resulting in a higher PAR (16.8%) and possibly a higher incidence of prostate cancer. morbidity. This allele was more strongly associated with aggressive prostate cancer.
[0263] Materials and methods
[0264] Icelandic Research Gro...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com